Related Experiment Video
Updated: Aug 11, 2026
10:49
Antibiotic Dereplication Using the Antibiotic Resistance Platform
Published on: October 17, 2019
Crystallizing new approaches for antimicrobial drug discovery
1Keck Graduate Institute, 535 Watson Drive, Claremont, CA 91711, USA. mschmid@kgi.edu
Biochemical Pharmacology
|February 7, 2006
Summary
Structural genomics and structure-guided drug discovery (SGDD) offer new strategies to overcome bottlenecks in developing novel antimicrobial agents, despite abundant genomic targets. This approach aims to accelerate the discovery of needed anti-infective drugs.
Area of Science:
- Microbiology
- Drug Discovery
- Genomics
Background:
- The accumulation of microbial genome sequences presents numerous targets for novel anti-infective agents.
- Despite abundant targets, the emergence of new antimicrobial drugs has been slow due to lengthy development times and discovery process bottlenecks.
- Key challenges include identifying promising lead compounds and optimizing them into viable drug candidates.
Purpose of the Study:
- To explore how structural genomics can address bottlenecks in antimicrobial drug discovery.
- To highlight the potential of structure-guided drug discovery (SGDD) in accelerating the development of new anti-infective agents.
Main Methods:
- Leveraging the outputs of structural genomics.
- Applying structure-guided drug discovery (SGDD) methodologies.
- Analyzing genomic data to identify novel drug targets.
Main Results:
- Structural genomics provides a wealth of potential targets for antimicrobial drug development.
- SGDD offers a pathway to overcome critical bottlenecks in lead identification and optimization.
- This approach has the potential to revitalize the antimicrobial drug pipeline.
Conclusions:
- Structural genomics and SGDD are crucial for overcoming challenges in antimicrobial drug discovery.
- These strategies can accelerate the identification and development of novel anti-infective agents.
- Filling the antimicrobial pipeline requires innovative approaches like SGDD.
Related Concept Videos
01:26Drug Discovery: Overview
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
01:27Production of Antibiotics
Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...